IDEAS home Printed from https://ideas.repec.org/a/spr/hecrev/v15y2025i1d10.1186_s13561-025-00609-8.html
   My bibliography  Save this article

A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

Author

Listed:
  • Cesare Aragona

    (Sapienza University
    The Experts Group on Inositol in Basic and Clinical Research)

  • Michele Russo

    (R&D Department)

  • Samuel H. Myers

    (R&D Department)

  • Maria Salomé Bezerra Espinola

    (Sapienza University
    The Experts Group on Inositol in Basic and Clinical Research)

  • Gabriele Bilotta

    (Alma Res Fertility Center)

  • Vittorio Unfer

    (The Experts Group on Inositol in Basic and Clinical Research
    UniCamillus – Saint Camillus International University of Health Sciences)

Abstract

Background Fertility care represents a financial burden on patients and healthcare services alike and can represent a barrier to entry for many couples. Controlled ovarian stimulation (COH) is routinely used as part of in vitro fertilization and intracytoplasmic sperm injection (ICSI) procedures, as such the use of gonadotropins is a major contributing factor to the cost of the procedure. Recent studies have shown that myo-Inositol (myo-ins) may reduce the amount of gonadotrophins required in assisted reproductive technology (ART) procedures. This retrospective study measured the effect of myo-ins on the number of recombinant follicular stimulating hormone (rFSH) units used in IVF and ICSI and the relative cost to verify if this may be a cost saving strategy. We also investigated the oocyte and embryo quality, implantation rate, abortion rate, clinical pregnancy, and ovarian hyperstimulation syndrome. Methods A total of 300 women undergoing either IVF or ICSI were distributed between two distinct and equal patient groups of 150 women. In control group (group A), folic acid (FA) alone was prescribed, meanwhile the treated group (group B) were prescribed FA, myo-Inositol (myo-ins) and alpha-lactalbumin (α-LA), both groups started this oral treatment in the middle of the luteal phase. Results Myo-Ins supplementation in the treatment group significantly reduced the number of units of rFSH used in COH vs. the control group (2526 vs. 1647, p

Suggested Citation

  • Cesare Aragona & Michele Russo & Samuel H. Myers & Maria Salomé Bezerra Espinola & Gabriele Bilotta & Vittorio Unfer, 2025. "A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”," Health Economics Review, Springer, vol. 15(1), pages 1-9, December.
    • Handle: RePEc:spr:hecrev:v:15:y:2025:i:1:d:10.1186_s13561-025-00609-8
    DOI: 10.1186/s13561-025-00609-8
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1186/s13561-025-00609-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1186/s13561-025-00609-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:hecrev:v:15:y:2025:i:1:d:10.1186_s13561-025-00609-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/13561 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.